< Back to catalogue
AdreView™
September 9, 2026Fludeoxyglucose (18F)/GE Healthcare
September 9, 2026PHARMAZAC
Sodium Iodide I-123
Sodium Iodide (123I) | Molecular Imaging | Radiopharmaceutical
| SODIUM IODIDE (I-123) INJ.SO.INF 37 MBq/ML BTx1 VIALx1 ML (1 mCi -10mCi/VIAL) |
| SODIUM IODIDE (I-123) INJ.SO.INF 37 MBq/ML BTx1 VIALx1 ML (1 mCi -10mCi/VIAL) |
| ACTIVE SUBSTANCE | |
|---|---|
| BUSINESS UNIT | |
| MARKETING AUTHORISATION HOLDER | |
| PHARMACOLOGICAL CLASS | |
| PRESCRIPTION REQUIREMENT | |
| THERAPEUTIC AREA |
